阿迪波金和它们在心力衰竭中的作用:文学评论
1Department of Zoology (Molecular Physiology), Lahore College for Women University, Lahore, Pakistan.
The Journal of innovations in cardiac rhythm management
|December 7, 2023
概括
与肥胖相关的荷尔蒙称为阿迪波金 (adipokines) 在心力衰竭 (HF) 的发展中起着关键作用. 本综述详细介绍了各种阿迪波金如何影响HF,提供了对疾病机制和潜在治疗点的见解.
科学领域:
- 内分泌学和新陈代谢学
- 心血管疾病病理生理学 病理生理学
- 分子生物学分子生物学
背景情况:
- 肥胖是心力衰竭 (HF) 的重要危险因素.
- 脂肪组织分泌的激素阿迪波金因在心血管健康和疾病中的作用得到越来越多的认可.
- 之前的研究已经涉及adipokines在HF的发病因子,但需要一个全面的摘要.
研究的目的:
- 综述和总结主要阿迪波金在心力衰竭 (HF) 病变发生过程中的作用.
- 巩固当前关于特定阿迪波金如何影响HF发育和进展的知识.
- 为了确定具有潜力作为HF的诊断或预后标记物的adipokines.
主要方法:
- 关于研究adipokines与心力衰竭之间的关联的文献综述.
- 对患有不同阶段和类型高血压的患者的阿迪波金水平数据的分析.
- 对阿迪波金对心脏组织的功能影响的实验证据的审查.
主要成果:
- 像阿佩林这样的特定阿迪波金在HF中降低,而其他如阿迪波内克丁和化学素则升高.
- 电阻素和视网醇结合蛋白4 (RBP4) 与高血压严重程度和心脏损伤有关.
- 莱普丁,奥门丁-1,利波卡林-2,和folistatin-like 1 (FSTL1) 显示与HF风险,严重程度或特定的HF亚型 (例如,HFpEF,HFrEF) 的相关性.
结论:
- 阿迪波金是心力衰竭病变的关键调解者,影响心脏重塑,炎症和纤维化.
- 几种阿迪波金具有作为HF风险分层和预后的新生物标志物的潜力.
- 在高血压的背景下,需要对PAI-1,MCP-1,nesfatin-1和progranulin等adipokines进行进一步的研究.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Heart Failure Drugs: Diuretics
396
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
396
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


